Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Madhu P. Menon"'
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms
Autor:
Amandeep Kaur, Alexandra E. Rojek, Emily Symes, Mariam T. Nawas, Anand A. Patel, Jay L. Patel, Payal Sojitra, Barina Aqil, Madina Sukhanova, Megan E. McNerney, Leo P. Wu, Aibek Akmatbekov, Jeremy Segal, Melissa Y. Tjota, Sandeep Gurbuxani, Jason X. Cheng, Su-Yeon Yeon, Harini V. Ravisankar, Carrie Fitzpatrick, Angela Lager, Michael W. Drazer, Caner Saygin, Pankhuri Wanjari, Panagiotis Katsonis, Olivier Lichtarge, Jane E. Churpek, Sharmila B. Ghosh, Ami B. Patel, Madhu P. Menon, Daniel A. Arber, Peng Wang, Girish Venkataraman
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Current therapies for high-grade TP53-mutated myeloid neoplasms (≥10% blasts) do not offer a meaningful survival benefit except allogeneic stem cell transplantation in the minority who achieve a complete response to first line therapy (CR1
Externí odkaz:
https://doaj.org/article/c0e050742d8c498c9f4fc3640be68aa0
Publikováno v:
Hemato, Vol 3, Iss 1, Pp 268-286 (2022)
Follicular helper T-cell (TFH) lymphomas comprise a unique group of T-cell lymphomas that represent neoplastic proliferations of follicular helper T-cells and share genetic, immunophenotypic, morphologic, and clinical features. Angioimmunoblastic T-c
Externí odkaz:
https://doaj.org/article/bd3d127554da46cb8eaf2c6ac97c1ad7
Autor:
Rohit Gulati, Yaser Alkhatib, Vijayalakshmi Donthireddy, Michelle Madden Felicella, Madhu P. Menon, Kedar V. Inamdar
Publikováno v:
Case Reports in Pathology, Vol 2015 (2015)
Blast phase in chronic myelogenous leukemia (CML) has rarely been reported to involve extramedullary sites like skin, lymph nodes, and central nervous system. Clinical history, characteristic hematologic findings (elevated leukocyte counts, myelocyti
Externí odkaz:
https://doaj.org/article/91d2ed8dd539485c80f7ff8d552ae7fb
Autor:
Anjanaa, Vijayanarayanan, Brandon, Shaw, Kathryn, Gibbons, Kedar V, Inamdar, Philip, Kuriakose, Madhu P, Menon
Publikováno v:
Blood Advances. 6:6210-6212
Autor:
Aliyah R. Sohani, Charles Van Slambrouck, Girish Venkataraman, Cheolwon Suh, Sylvia Hartmann, Paola Dama, James Godfrey, Jooryung Huh, Reva C. Goldberg, Madhu P. Menon, Elaine S. Jaffe, Joo Y. Song, Carrie Fitzpatrick, Amy S. Duffield, Justin Kline, Kazuma Kiyotani, Sonali M. Smith
Publikováno v:
Modern Pathology. 33:834-845
Although the distinction of classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma using morphology and immunostains is straightforward in most instances, occasional cases pose diagnostic challenge. We sought to determine the
Publikováno v:
New England Journal of Medicine. 387:1021-1021
Publikováno v:
Indian Journal of Dermatology, Vol 65, Iss 3, Pp 222-224 (2020)
Indian Journal of Dermatology
Indian Journal of Dermatology
Publikováno v:
Clinical Case Reports
Follicular lymphoma (FL) is an indolent subtype of non‐Hodgkin lymphoma (NHL). Transformation of FL (TL) to an aggressive lymphoma is a well‐recognized phenomenon. FLs most commonly transform to diffuse large cell lymphoma (DLBCL).1 Based on lite
Autor:
Girish Venkataraman, Brie Kezlarian, Mohammad Alhyari, Madhu P. Menon, Kedar V. Inamdar, Kristin H. Karner
Publikováno v:
Applied Immunohistochemistry & Molecular Morphology. 27:180-184
Classic Hodgkin lymphoma (CHL) and nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) are clinically distinct entities, with different prognostic and treatment implications. In addition, several large B-cell lymphomas and some T-cell lymphomas c
Publikováno v:
Journal of Hematopathology. 11:107-113
Gamma delta T cells represent a minor subset of the normal lymphocyte component of the human immune system, largely inhabiting mucosal surfaces. Gamma delta T cell lymphomas (γδ TCLs) are thought to be derived from these cells and are rare, extreme